Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hypertension


Dyslipidemias
ACTIVE_NOT_RECRUITING
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
2,845 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hyperlipidemias


Hypertension
NOT_YET_RECRUITING
NCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Nephrotic Syndrome


Hypoalbuminemia
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction


Dual Antiplatelet Therapy
COMPLETED
NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
1 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Autosomal Dominant Polycystic Kidney Disease
RECRUITING
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia in Children
COMPLETED
NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
70 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
RECRUITING
NCT07073755
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
200 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer


Drug Resistance


Hormone Receptor-Positive Breast Cancer


HER2-positive Breast Cancer


Triple-Negative Breast Cancer (TNBC)


Treatment Decisions